{"id":"NCT03987919","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes","officialTitle":"A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-07-30","primaryCompletion":"2021-01-28","completion":"2021-02-15","firstPosted":"2019-06-17","resultsPosted":"2022-02-14","lastUpdate":"2022-02-14"},"enrollment":1879,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"Tirzepatide","otherNames":["LY3298176"]},{"type":"DRUG","name":"Semaglutide","otherNames":[]}],"arms":[{"label":"5 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"10 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"15 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"1 mg Semaglutide","type":"ACTIVE_COMPARATOR"}],"summary":"The reason for this study is to compare the effect of the study drug tirzepatide to semaglutide on blood sugar levels in participants with type 2 diabetes. The study will last approximately 47 weeks and may include about 12 visits.","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin A1c (HbA1c) (10 mg and 15 mg)","timeFrame":"Baseline, Week 40","effectByArm":[{"arm":"10 mg Tirzepatide","deltaMin":-2.37,"sd":0.048},{"arm":"15 mg Tirzepatide","deltaMin":-2.46,"sd":0.048},{"arm":"1 mg Semaglutide","deltaMin":-1.86,"sd":0.048}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":10},"locations":{"siteCount":127,"countries":["United States","Argentina","Australia","Brazil","Canada","Israel","Mexico","Puerto Rico","United Kingdom"]},"refs":{"pmids":["39531161","38777128","37668888","37526908","37415503","37000390","35489606","35210595","34170647"],"seeAlso":["https://trials.lillytrialguide.com/en-US/trial/4c6UpSKPWegDblIILD6NMM"]},"adverseEventsSummary":{"seriousAny":{"events":33,"n":470},"commonTop":["Nausea","Diarrhoea","Vomiting","Dyspepsia","Decreased appetite"]}}